India has spent two decades building itself into one of the world’s busiest medical tourism destinations, and a single regional conflict has now exposed how much of that trade rests on a narrow band of geography. According to The New Indian Express, international patient arrivals have fallen sharply across India’s leading hospitals, driven by the conflict in West Asia and the flight disruptions that have followed it. Arrivals are down between 30 and 40 per cent, and medical tourism-linked revenue has fallen by a similar margin across the country’s principal medical hubs.
Those hubs span the National Capital Region, Maharashtra, Tamil Nadu, Karnataka and Telangana, the states that together handle most of India’s international patient care. The New Indian Express reported that the contraction has accelerated in recent weeks, with overseas patient inflow dropping by 50 to 75 per cent over a single fortnight. Certain hospital chains recorded an even steeper fall, with patients from West Asia down by around 75 per cent.
West Asia Conflict Cuts India’s Patient Inflow
The financial reading came from Dr Abhay Sinha, director general of the Services Export Promotion Council, a body set up by the Ministry of Commerce and Industry to develop overseas markets for India’s services exports. Sinha put the monthly revenue decline at 15 to 20 per cent across the sector, with some facilities reporting a dip of around 35 per cent, and medical tourism-linked revenue down 30 to 40 per cent in certain Delhi hospitals. He described the early damage as limited, then sharply worse: “Initial impact was minimal due to pre-booked patients, but new registrations have dropped sharply.”
That distinction matters more than the headline percentages. A pipeline of pre-booked patients masks a collapse in new demand for a few weeks, and then the shortfall arrives all at once. West Asia has historically supplied between 18 and 30 per cent of India’s international patients, a concentration that now reads as exposure rather than strength. The inflow from that one corridor is precisely the inflow now missing from the wards, and no amount of pricing can conjure it back while the airfares stay high and the routes stay shut.
Flight Disruption Drives the Medical Tourism Decline
The immediate cause is logistical rather than clinical. According to The New Indian Express, widespread flight cancellations have hit the region, and where routes remain open, airfares have climbed by an estimated 15 to 25 per cent. Those barriers fall hardest on elective procedures, which can be postponed without clinical penalty, and the segments hit worst are plastic surgery, geriatrics, orthopaedics and fertility treatment. Those elective patients, the geriatrics and orthopaedics cases in particular, can defer for months without any clinical penalty at all. Patients who can wait are waiting. Those who cannot travel are cancelling.
Sinha noted that hospitals in South India have weathered the disruption more comfortably, helped by alternative air routes that keep patients moving. That detail carries a wider lesson for any medical tourism destination. Connectivity is infrastructure. A hospital’s catchment is only as reliable as the flight map that feeds it, a point that rarely appears in destination marketing but decides whether patients actually arrive.
Fortis Healthcare and Paras Health Report Sharp Falls
The New Indian Express reported figures from two of India’s larger hospital operators that put numbers to the disruption. Anil Vinayak, group chief operating officer at Fortis Healthcare, said that comparing the last ten days of February with the first ten days of March showed inflow from the Middle East down by 75 per cent. He was cautious about any quick recovery, describing the situation as highly uncertain and the coming weeks as decisive for whether regional travel begins to normalise. The Fortis inflow from the Middle East had gone to almost nothing, and Vinayak was clear that the Fortis figures track what smaller operators report privately.
The disruption reaches past new bookings into continuity of care, which is the quieter and more serious problem. Dr Dharminder Nagar, managing director of Paras Health and co-chair of the FICCI Healthcare Committee, said that patients who once travelled every three to six months for cardiology, oncology, transplants and orthopaedics could no longer visit because of flight disruptions, visa delays and travel uncertainty. Those are not elective cosmetic cases that can slip a quarter. A patient on an oncology protocol or a transplant follow-up cannot defer the next review the way an orthopaedics or a cardiology case sometimes can. Interrupted follow-up for a transplant or an oncology patient carries real clinical risk, and it is the kind of harm that never shows up in a revenue chart.
Diversifying Source Markets for Medical Tourism Resilience
Worried about a prolonged conflict, several hospital groups are actively courting new source markets to rebuild their international patient books. According to The New Indian Express, the pivot runs away from West Asia towards South and Southeast Asia, including Indonesia and Sri Lanka, towards parts of Africa such as Nigeria, Kenya and Mauritius, and towards Central Asia. The logic is sound. It is also slow. None of those markets, from Indonesia and Sri Lanka to Nigeria, Kenya and Mauritius, will replace the Gulf inside a year, and none of them sits on the same short-haul flight paths that once fed the hospitals in Delhi. Source markets are built over years through referral networks, language support and trust, and they cannot be switched on inside a single disrupted quarter.
The episode is a stress test that the wider medical tourism sector should study rather than watch. A destination that draws a third of its patients from one region has bought concentration risk, and the four familiar hazards of medical travel now plainly include a geopolitical and logistical one alongside the clinical, legal and continuity-of-care risks. India retains the assets that built the trade, competitive pricing and genuine clinical depth, and those will pull patients back once the routes reopen. Lower airfares and open routes will restore the inflow faster than any campaign, and the airfares are the one variable that operators cannot control. The durable lesson for operators is narrower: diversify the source markets and the flight paths before the next shock, not during it.
